Genmab — Maj 2016
-
Stillingsopslag i Utrecht. Puha de stiller store krav https://www.slideshare.net/slideshow/embed_code/key/lDtDbikE0S1ayb
-
May 10 (Reuters) - Medivation Inc MDVN.O will actively seek to sell itself after the US cancer drug maker rejected a $9.3 billion takeover offer from France's Sanofi SA SASY.PA, according to people familiar with the situation.
The San Francisco-based company has agreed to open its books to both Pfizer Inc PFE.N and Amgen Inc AMGN.O, those people said.
The move comes less than two weeks after Sanofi made its approach public by publishing a letter to Medivation's chief executive David Hung that co -
Jan har sagt til Algeme Dagblad at der skal være 100% præmie ved bud. Altså + 2000

-
Ja OK, jeg mener godt man kan forsvare at betale 2000 for Genmab hvis Darzalex salget om 6-10 år er + 10 milliarder usd
-
Hvis man ser på Revlimid er det jo opnåeligt, da Darzalex er den nye Revlimid, der vil blive brugt i alle mulige kombier
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
